Venture Life Group (VLG) Competitors GBX 55 -1.00 (-1.79%) As of 10/3/2025 12:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock VLG vs. BXP, ANCR, STX, EAH, DNL, PXS, MXC, RGT, CEL, and CHLLShould you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Shield Therapeutics (STX), ECO Animal Health Group (EAH), Diurnal Group (DNL), Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and Chill Brands Group (CHLL). These companies are all part of the "drug manufacturers - specialty & generic" industry. Venture Life Group vs. Its Competitors Beximco Pharmaceuticals Animalcare Group Shield Therapeutics ECO Animal Health Group Diurnal Group Provexis Argent BioPharma Argent BioPharma Celadon Pharmaceuticals Chill Brands Group Venture Life Group (LON:VLG) and Beximco Pharmaceuticals (LON:BXP) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Is VLG or BXP more profitable? Beximco Pharmaceuticals has a net margin of 13.71% compared to Venture Life Group's net margin of 1.44%. Beximco Pharmaceuticals' return on equity of 13.12% beat Venture Life Group's return on equity.Company Net Margins Return on Equity Return on Assets Venture Life Group1.44% 0.99% 1.56% Beximco Pharmaceuticals 13.71%13.12%6.97% Which has preferable earnings and valuation, VLG or BXP? Beximco Pharmaceuticals has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Beximco Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenture Life Group£31.23M2.26£747.21K-£0.01-7,236.84Beximco Pharmaceuticals£46.34B0.00£970.84B£14.253.09 Does the media refer more to VLG or BXP? In the previous week, Venture Life Group had 7 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 7 mentions for Venture Life Group and 0 mentions for Beximco Pharmaceuticals. Venture Life Group's average media sentiment score of 1.48 beat Beximco Pharmaceuticals' score of 0.00 indicating that Venture Life Group is being referred to more favorably in the media. Company Overall Sentiment Venture Life Group Positive Beximco Pharmaceuticals Neutral Which has more volatility & risk, VLG or BXP? Venture Life Group has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Beximco Pharmaceuticals has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Do insiders and institutionals have more ownership in VLG or BXP? 37.4% of Venture Life Group shares are held by institutional investors. Comparatively, 1.2% of Beximco Pharmaceuticals shares are held by institutional investors. 6.8% of Venture Life Group shares are held by company insiders. Comparatively, 4.2% of Beximco Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryBeximco Pharmaceuticals beats Venture Life Group on 8 of the 13 factors compared between the two stocks. Get Venture Life Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLG vs. The Competition Export to ExcelMetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£71.71M£1.74B£6.12B£2.59BDividend Yield0.09%2.95%5.65%5.30%P/E Ratio-7,236.84116.3786.964,424.90Price / Sales2.261,568.89605.8899,677.99Price / Cash6.4010.3737.9027.90Price / Book0.9411.4912.558.04Net Income£747.21K£20.70B£3.31B£5.89B7 Day Performance1.85%4.45%4.28%4.35%1 Month Performance-8.21%4.25%6.90%6.26%1 Year Performance22.22%9.68%70.54%143.90% Venture Life Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLGVenture Life GroupN/AGBX 55-1.8%N/A+19.6%£71.71M£31.23M-7,236.84165News CoveragePositive NewsEarnings ReportInsider TradeHigh Trading VolumeBXPBeximco PharmaceuticalsN/AGBX 44-3.3%N/A+79.6%£196.29M£46.34B3.095,500Gap DownANCRAnimalcare GroupN/AGBX 236+0.9%N/A+0.9%£162.81M£74.23M789.30220Earnings ReportSTXShield Therapeutics1.7129 of 5 starsGBX 7.80flatGBX 15+92.3%+90.1%£81.25M£41.50M-390.0040,000Analyst ForecastEAHECO Animal Health Group2.7362 of 5 starsGBX 94.35+0.4%GBX 150+59.0%+33.2%£63.68M£79.60M3,882.72234DNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133PXSProvexisN/AGBX 0.62flatN/A+2.9%£14.49M£1.20M-2,058.334MXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading VolumeCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780CHLLChill Brands GroupN/AGBX 1.58+1.7%N/AN/A£7.98M£305.70K-242.627Gap Down Related Companies and Tools Related Companies Beximco Pharmaceuticals Competitors Animalcare Group Competitors Shield Therapeutics Competitors ECO Animal Health Group Competitors Diurnal Group Competitors Provexis Competitors Argent BioPharma Competitors Argent BioPharma Competitors Celadon Pharmaceuticals Competitors Chill Brands Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VLG) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venture Life Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Venture Life Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
